DE69929444D1 - Cpg-zusammensetzungen, saponin-adjuvantien und verfahren zu deren verwendung - Google Patents
Cpg-zusammensetzungen, saponin-adjuvantien und verfahren zu deren verwendungInfo
- Publication number
- DE69929444D1 DE69929444D1 DE69929444T DE69929444T DE69929444D1 DE 69929444 D1 DE69929444 D1 DE 69929444D1 DE 69929444 T DE69929444 T DE 69929444T DE 69929444 T DE69929444 T DE 69929444T DE 69929444 D1 DE69929444 D1 DE 69929444D1
- Authority
- DE
- Germany
- Prior art keywords
- compositions
- saponin
- adjuvanties
- cpg
- immunostimulatory oligonucleotides
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Lifetime
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/02—Bacterial antigens
- A61K39/095—Neisseria
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/39—Medicinal preparations containing antigens or antibodies characterised by the immunostimulating additives, e.g. chemical adjuvants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/04—Immunostimulants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
- A61K2039/55511—Organic adjuvants
- A61K2039/55561—CpG containing adjuvants; Oligonucleotide containing adjuvants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
- A61K2039/55511—Organic adjuvants
- A61K2039/55577—Saponins; Quil A; QS21; ISCOMS
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
- Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
- Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Immunology (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Mycology (AREA)
- Microbiology (AREA)
- Epidemiology (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Engineering & Computer Science (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Steroid Compounds (AREA)
Applications Claiming Priority (5)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US9591398P | 1998-08-10 | 1998-08-10 | |
US95913P | 1998-08-10 | ||
US12860899P | 1999-04-08 | 1999-04-08 | |
US128608P | 1999-04-08 | ||
PCT/US1999/017956 WO2000009159A1 (en) | 1998-08-10 | 1999-08-06 | Compositions of cpg and saponin adjuvants and methods thereof |
Publications (2)
Publication Number | Publication Date |
---|---|
DE69929444D1 true DE69929444D1 (de) | 2006-04-06 |
DE69929444T2 DE69929444T2 (de) | 2006-09-28 |
Family
ID=26790746
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
DE69929444T Expired - Lifetime DE69929444T2 (de) | 1998-08-10 | 1999-08-06 | Cpg-zusammensetzungen, saponin-adjuvantien und verfahren zu deren verwendung |
Country Status (11)
Country | Link |
---|---|
US (2) | US7049302B1 (de) |
EP (1) | EP1104306B1 (de) |
JP (1) | JP4620251B2 (de) |
AT (1) | ATE315405T1 (de) |
AU (1) | AU773204C (de) |
CA (1) | CA2340174C (de) |
DE (1) | DE69929444T2 (de) |
DK (1) | DK1104306T3 (de) |
ES (1) | ES2257068T3 (de) |
PT (1) | PT1104306E (de) |
WO (1) | WO2000009159A1 (de) |
Families Citing this family (94)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20030026782A1 (en) | 1995-02-07 | 2003-02-06 | Arthur M. Krieg | Immunomodulatory oligonucleotides |
US6207646B1 (en) | 1994-07-15 | 2001-03-27 | University Of Iowa Research Foundation | Immunostimulatory nucleic acid molecules |
US6406705B1 (en) | 1997-03-10 | 2002-06-18 | University Of Iowa Research Foundation | Use of nucleic acids containing unmethylated CpG dinucleotide as an adjuvant |
US6589940B1 (en) | 1997-06-06 | 2003-07-08 | Dynavax Technologies Corporation | Immunostimulatory oligonucleotides, compositions thereof and methods of use thereof |
US20020147143A1 (en) | 1998-03-18 | 2002-10-10 | Corixa Corporation | Compositions and methods for the therapy and diagnosis of lung cancer |
DE69932717T2 (de) | 1998-05-22 | 2007-08-09 | Ottawa Health Research Institute, Ottawa | Methoden und produkte zur induzierung mukosaler immunität |
DE69929444T2 (de) * | 1998-08-10 | 2006-09-28 | Antigenics Inc., Woburn | Cpg-zusammensetzungen, saponin-adjuvantien und verfahren zu deren verwendung |
US20030235557A1 (en) | 1998-09-30 | 2003-12-25 | Corixa Corporation | Compositions and methods for WT1 specific immunotherapy |
US7776343B1 (en) * | 1999-02-17 | 2010-08-17 | Csl Limited | Immunogenic complexes and methods relating thereto |
GB9908885D0 (en) * | 1999-04-19 | 1999-06-16 | Smithkline Beecham Biolog | Vccine |
WO2000062800A2 (en) * | 1999-04-19 | 2000-10-26 | Smithkline Beecham Biologicals Sa | Adjuvant composition comprising saponin and an immunostimulatory oligonucleotide |
US6558670B1 (en) | 1999-04-19 | 2003-05-06 | Smithkline Beechman Biologicals S.A. | Vaccine adjuvants |
JP2003514872A (ja) * | 1999-11-19 | 2003-04-22 | シーエスエル、リミテッド | ワクチン組成物 |
AU781812B2 (en) * | 2000-01-13 | 2005-06-16 | Antigenics, Inc. | Innate immunity-stimulating compositions of CPG and saponin and methods thereof |
CA2400842C (en) | 2000-02-23 | 2013-01-15 | Smithkline Beecham Biologicals S.A. | Novel compounds |
CA2413959C (en) | 2000-06-20 | 2015-07-07 | Corixa Corporation | Fusion proteins of mycobacterium tuberculosis |
WO2002000174A2 (en) | 2000-06-28 | 2002-01-03 | Corixa Corporation | Compositions and methods for the therapy and diagnosis of lung cancer |
UA79735C2 (uk) | 2000-08-10 | 2007-07-25 | Глаксосмітклайн Байолоджікалз С.А. | Очищення антигенів вірусу гепатиту b (hbv) для використання у вакцинах |
EP2266603B1 (de) * | 2000-10-18 | 2012-09-12 | GlaxoSmithKline Biologicals S.A. | Impfstoffe gegen Krebs |
ES2295229T3 (es) * | 2000-10-18 | 2008-04-16 | Glaxosmithkline Biologicals S.A. | Vacunas contra canceres. |
EP1988097A1 (de) | 2001-05-09 | 2008-11-05 | Corixa Corporation | Zusammensetzungen und Verfahren zur Behandlung und Diagnose von Prostatakrebs |
CN1599623B (zh) | 2001-09-14 | 2011-05-11 | 赛托斯生物技术公司 | 免疫刺激物向病毒样颗粒内的包装:制备方法与用途 |
WO2003053220A2 (en) | 2001-12-17 | 2003-07-03 | Corixa Corporation | Compositions and methods for the therapy and diagnosis of inflammatory bowel disease |
CA2471092A1 (en) * | 2001-12-21 | 2003-07-10 | Antigenics Inc. | Compositions comprising immunoreactive reagents and saponins, and methods of use thereof |
AU2003242742B2 (en) * | 2002-06-20 | 2009-04-30 | Cytos Biotechnology Ag | Packaged virus-like particles for use as adjuvants: method of preparation and use |
JP2005532405A (ja) * | 2002-07-10 | 2005-10-27 | アクゾ・ノベル・エヌ・ベー | 融合タンパク質とサポニンアジュバントとを含む免疫原性組成物 |
AU2003300919A1 (en) | 2002-12-11 | 2004-06-30 | Coley Pharmaceutical Gmbh | 5' cpg nucleic acids and methods of use |
US20040235770A1 (en) * | 2003-04-02 | 2004-11-25 | Coley Pharmaceutical Group, Ltd. | Immunostimulatory nucleic acid oil-in-water formulations and related methods of use |
AU2004308964B2 (en) | 2003-12-23 | 2010-09-16 | Arbor Vita Corporation | Antibodies for oncogenic strains of HPV and methods of their use |
WO2005072290A2 (en) * | 2004-01-23 | 2005-08-11 | Joslin Diabetes Center | Methods of treating, reducing, or preventing autoimmune conditions |
AU2005249212B2 (en) | 2004-05-28 | 2010-05-20 | Glaxosmithkline Biologicals S.A. | Vaccine compositions comprising virosomes and a saponin adjuvant |
EP2392349A3 (de) | 2005-03-31 | 2012-01-18 | GlaxoSmithKline Biologicals S.A. | Impfstoffe gegen Chlamydieninfektion |
AR061136A1 (es) | 2006-06-02 | 2008-08-06 | Glaxosmithkline Biolog Sa | Procedimiento |
WO2008057529A2 (en) * | 2006-11-06 | 2008-05-15 | Coley Pharmaceutical Group, Inc. | Peptide-based vaccine compositions to endogenous cholesteryl ester transfer protein (cetp) |
DK2136836T3 (en) | 2007-04-04 | 2017-04-10 | Infectious Disease Res Inst | Immunogenic compositions with mycobacterium tuberculosis polypeptides and fusions thereof |
US8518903B2 (en) | 2007-04-19 | 2013-08-27 | University of Pittsburgh—of the Commonwealth System of Higher Education | Use of toll-like receptor-9 agonists |
US8188058B2 (en) | 2007-04-19 | 2012-05-29 | University of Pittsburgh—of the Commonwealth System of Higher Education | Use of toll-like receptor-9 agonists, toll-like receptor-4 antagonists, and/or nuclear oligomerization domain-2 agonists for the treatment or prevention of toll-like receptor-4-associated disorders |
CL2008001491A1 (es) * | 2007-05-24 | 2008-11-28 | Glaxosmithkline Biolog Sa | Composicion liofilizada que comprende uno o mas antigenos y un agonista del receptor de tipo toll 9 (tlr9); y procedimiento de preparacion. |
CN101932723B (zh) | 2007-09-17 | 2014-09-10 | 肿瘤甲基化科学公司 | 改进的对mage-a表达的检测 |
NZ602945A (en) | 2008-06-27 | 2014-05-30 | Zoetis Llc | Novel adjuvant compositions |
TW201010719A (en) * | 2008-08-19 | 2010-03-16 | Wyeth Corp | Immunological composition |
CA2744987C (en) | 2008-12-02 | 2018-01-16 | Chiralgen, Ltd. | Method for the synthesis of phosphorus atom modified nucleic acids |
EP2202298A1 (de) | 2008-12-23 | 2010-06-30 | Stichting Dienst Landbouwkundig Onderzoek | Rekombinantes Virus der klassischen Schweinepest (KSP) mit einem modifizierten E2-Protein und Verfahren zur Erzeugung des besagten Klassiche-Schweinepest-Virus |
BRPI0923598A2 (pt) * | 2008-12-23 | 2016-01-26 | Intervet Int Bv | composição farmacêutica, e, uso de uma composição farmacêutica |
KR20120002534A (ko) | 2009-03-17 | 2012-01-05 | 엠디엑스헬스 에스에이 | 유전자 발현의 향상된 검출 |
BR112012000828A8 (pt) | 2009-07-06 | 2017-10-10 | Ontorii Inc | Novas pró-drogas de ácido nucleico e métodos de uso das mesmas |
GB0917457D0 (en) | 2009-10-06 | 2009-11-18 | Glaxosmithkline Biolog Sa | Method |
CA2800158C (en) | 2010-05-28 | 2020-07-21 | Coley Pharmaceutical Group, Inc. | Vaccines comprising cholesterol and cpg as sole adjuvant-carrier molecules |
US9072760B2 (en) | 2010-09-24 | 2015-07-07 | University of Pittsburgh—of the Commonwealth System of Higher Education | TLR4 inhibitors for the treatment of human infectious and inflammatory disorders |
US10668092B2 (en) | 2010-09-24 | 2020-06-02 | The John Hopkins University | Compositions and methods for treatment of inflammatory disorders |
WO2012039448A1 (ja) | 2010-09-24 | 2012-03-29 | 株式会社キラルジェン | 不斉補助基 |
WO2012057904A1 (en) | 2010-10-27 | 2012-05-03 | Infectious Disease Research Institute | Mycobacterium tuberculosis antigens and combinations thereof having high seroreactivity |
WO2012064659A1 (en) | 2010-11-08 | 2012-05-18 | Infectious Disease Research Institute | Vaccines comprising non-specific nucleoside hydrolase and sterol 24-c-methyltransferase (smt) polypeptides for the treatment and diagnosis of leishmaniasis |
WO2012088425A2 (en) | 2010-12-22 | 2012-06-28 | University Of Pittsburgh - Of The Commonwealth System Of Higher Education | Gap junction-enhancing agents for treatment of necrotizing enterocolitis and inflammatory bowel disease |
GB201106357D0 (en) | 2011-04-14 | 2011-06-01 | Pessi Antonello | Composition and uses thereof |
US20150030586A1 (en) | 2011-06-21 | 2015-01-29 | Sarah Ellen Warren | Compositions and methods for the therapy and diagnosis of cancer |
US9605019B2 (en) | 2011-07-19 | 2017-03-28 | Wave Life Sciences Ltd. | Methods for the synthesis of functionalized nucleic acids |
KR20220139425A (ko) | 2012-07-13 | 2022-10-14 | 웨이브 라이프 사이언시스 리미티드 | 키랄 제어 |
AU2013288048A1 (en) | 2012-07-13 | 2015-01-22 | Wave Life Sciences Ltd. | Asymmetric auxiliary group |
EP4299138A2 (de) | 2012-08-03 | 2024-01-03 | Access to Advanced Health Institute | Zusammensetzungen und verfahren zur behandlung einer aktiven mycobakterium-tuberkuloseinfektion |
US9562066B2 (en) | 2012-09-25 | 2017-02-07 | University Of Pittsburgh-Of The Commonwealth System Of Higher Education | Oral therapy of necrotizing enterocolitis |
BR112015024860B1 (pt) | 2013-03-28 | 2023-11-07 | Access To Advanced Health Institute | Polipeptídeo de fusão, polinucleotídeo isolado, composição compreendendo dito polipeptídeo, uso da dita composição para estimular uma resposta imune contra leishmania e método in vitro e kit de diagnóstico para detectar infecção por leishmania em uma amostra biológica |
CN109675026A (zh) | 2013-09-19 | 2019-04-26 | 硕腾服务有限责任公司 | 油基佐剂 |
US10322173B2 (en) | 2014-01-15 | 2019-06-18 | Shin Nippon Biomedical Laboratories, Ltd. | Chiral nucleic acid adjuvant having anti-allergic activity, and anti-allergic agent |
EP3095461A4 (de) * | 2014-01-15 | 2017-08-23 | Shin Nippon Biomedical Laboratories, Ltd. | Chirales nukleinsäure-adjuvans mit immunitätsinduktionswirkung und immunitätsinduktionsaktivator |
WO2015108048A1 (ja) * | 2014-01-15 | 2015-07-23 | 株式会社新日本科学 | 抗腫瘍作用を有するキラル核酸アジュバンド及び抗腫瘍剤 |
PT3094728T (pt) | 2014-01-16 | 2022-05-19 | Wave Life Sciences Ltd | Desenho quiral |
KR102433464B1 (ko) | 2014-05-28 | 2022-08-17 | 아게누스 인코포레이티드 | 항-gitr 항체 및 이의 사용 방법 |
AR102547A1 (es) | 2014-11-07 | 2017-03-08 | Takeda Vaccines Inc | Vacunas contra la enfermedad de manos, pies y boca y métodos de fabricación y su uso |
AR102548A1 (es) | 2014-11-07 | 2017-03-08 | Takeda Vaccines Inc | Vacunas contra la enfermedad de manos, pies y boca y métodos de fabricación y uso |
SI3244920T1 (sl) | 2015-01-16 | 2023-09-29 | The United States of America, represented by The Secretary of Agriculture, United States Department of Agriculture | Cepivo proti slinavki in parkljevki |
BR112017018017A2 (pt) * | 2015-02-26 | 2018-04-10 | Thevax Genetics Vaccine Co Ltd | composição de vacina compreendendo uma proteína imunogênica e adjuvantes de combinação para uso na promoção de respostas de células t específicas de antigenos |
US10568948B2 (en) | 2015-05-13 | 2020-02-25 | Agenus Inc. | Vaccines for treatment and prevention of cancer |
RU2017140856A (ru) | 2015-05-26 | 2019-06-26 | Огайо Стейт Инновейшн Фаундейшн | Стратегия вакцинации против вируса свиного гриппа вакциной на основе наночастиц |
US10456459B2 (en) | 2015-07-20 | 2019-10-29 | Zoetis Services Llc | Liposomal adjuvant compositions |
US10323091B2 (en) | 2015-09-01 | 2019-06-18 | Agenus Inc. | Anti-PD-1 antibodies and methods of use thereof |
CN116063542A (zh) | 2015-12-02 | 2023-05-05 | 阿吉纳斯公司 | 抗体和其使用方法 |
MX2018014270A (es) | 2016-05-21 | 2019-02-14 | Infectious Disease Res Inst | Composiciones y metodos para tratar la tuberculosis secundaria e infecciones po micobacteria no tuberculosa. |
SG10201912563XA (en) | 2016-05-27 | 2020-02-27 | Agenus Inc | Anti-tim-3 antibodies and methods of use thereof |
US11801290B2 (en) | 2016-09-16 | 2023-10-31 | Access To Advanced Health Institute | Vaccines comprising Mycobacterium leprae polypeptides for the prevention, treatment, and diagnosis of leprosy |
KR20230133934A (ko) | 2016-10-11 | 2023-09-19 | 아게누스 인코포레이티드 | 항-lag-3 항체 및 이의 사용 방법 |
WO2018132739A2 (en) | 2017-01-13 | 2018-07-19 | Agenus Inc. | T cell receptors that bind to ny-eso-1 and methods of use thereof |
KR102629972B1 (ko) | 2017-04-13 | 2024-01-29 | 아게누스 인코포레이티드 | 항-cd137 항체 및 이의 사용 방법 |
MA50957A (fr) | 2017-05-01 | 2020-10-14 | Agenus Inc | Anticorps anti-tigit et leurs méthodes d'utilisation |
WO2019035963A1 (en) | 2017-08-16 | 2019-02-21 | Ohio State Innovation Foundation | NANOPARTICLE COMPOSITIONS FOR VACCINES AGAINST SALMONELLA |
CN107537035A (zh) * | 2017-08-30 | 2018-01-05 | 北京恩元华生物科技有限公司 | 复合佐剂及含复合佐剂的狂犬疫苗及其制备方法和应用 |
AU2018326875A1 (en) | 2017-09-04 | 2020-03-19 | Agenus Inc. | T cell receptors that bind to mixed lineage leukemia (MLL)-specific phosphopeptides and methods of use thereof |
MX2020004543A (es) | 2017-11-03 | 2020-09-18 | Takeda Vaccines Inc | Vacunas contra el zika, composiciones inmunogenicas y metodos que las utilizan. |
MA52363A (fr) | 2018-04-26 | 2021-03-03 | Agenus Inc | Compositions peptidiques de liaison à une protéine de choc thermique (hsp) et leurs méthodes d'utilisation |
GB201901608D0 (en) | 2019-02-06 | 2019-03-27 | Vib Vzw | Vaccine adjuvant conjugates |
US11680098B2 (en) | 2019-08-30 | 2023-06-20 | Agenus Inc. | Antibodies that specifically bind human CD96 |
CA3161638A1 (en) * | 2019-12-13 | 2021-06-17 | Jun Ge | Pharmaceutical composition and use thereof |
US20230287038A1 (en) | 2020-08-07 | 2023-09-14 | Access To Advanced Health Institute | Purified saponins and chromatographic process for purification of same |
EP4326237A2 (de) * | 2021-04-23 | 2024-02-28 | Flow Pharma Inc. | Mikrokugelformulierungen mit mehreren ungleichen peptiden und verfahren zur herstellung davon |
Family Cites Families (41)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4469863A (en) | 1980-11-12 | 1984-09-04 | Ts O Paul O P | Nonionic nucleic acid alkyl and aryl phosphonates and processes for manufacture and use thereof |
US5023243A (en) | 1981-10-23 | 1991-06-11 | Molecular Biosystems, Inc. | Oligonucleotide therapeutic agent and method of making same |
US4522811A (en) | 1982-07-08 | 1985-06-11 | Syntex (U.S.A.) Inc. | Serial injection of muramyldipeptides and liposomes enhances the anti-infective activity of muramyldipeptides |
US5352449A (en) | 1986-05-30 | 1994-10-04 | Cambridge Biotech Corporation | Vaccine comprising recombinant feline leukemia antigen and saponin adjuvant |
US5583112A (en) | 1987-05-29 | 1996-12-10 | Cambridge Biotech Corporation | Saponin-antigen conjugates and the use thereof |
US5057540A (en) | 1987-05-29 | 1991-10-15 | Cambridge Biotech Corporation | Saponin adjuvant |
US5273965A (en) | 1992-07-02 | 1993-12-28 | Cambridge Biotech Corporation | Methods for enhancing drug delivery with modified saponins |
US5650398A (en) | 1992-07-02 | 1997-07-22 | Cambridge Biotech Corporation | Drug delivery enhancement via modified saponins |
ES2326118T3 (es) * | 1993-09-20 | 2009-10-01 | The Trustees Of The University Of Pennsylvania | Regulacion de la expresion del gen bcl-2. |
WO1995026204A1 (en) | 1994-03-25 | 1995-10-05 | Isis Pharmaceuticals, Inc. | Immune stimulation by phosphorothioate oligonucleotide analogs |
US6207646B1 (en) * | 1994-07-15 | 2001-03-27 | University Of Iowa Research Foundation | Immunostimulatory nucleic acid molecules |
US6429199B1 (en) * | 1994-07-15 | 2002-08-06 | University Of Iowa Research Foundation | Immunostimulatory nucleic acid molecules for activating dendritic cells |
ATE420171T1 (de) * | 1994-07-15 | 2009-01-15 | Univ Iowa Res Found | Immunomodulatorische oligonukleotide |
US6239116B1 (en) * | 1994-07-15 | 2001-05-29 | University Of Iowa Research Foundation | Immunostimulatory nucleic acid molecules |
AUPM873294A0 (en) | 1994-10-12 | 1994-11-03 | Csl Limited | Saponin preparations and use thereof in iscoms |
US6335018B1 (en) * | 1995-05-01 | 2002-01-01 | Aventis Pasteur Limited | High molecular weight major outer membrane protein of moraxella |
US5968909A (en) * | 1995-08-04 | 1999-10-19 | Hybridon, Inc. | Method of modulating gene expression with reduced immunostimulatory response |
US6231859B1 (en) | 1996-12-02 | 2001-05-15 | Aquila Biopharmaceuticals, Inc. | Saponin adjuvant compositions |
WO1998037919A1 (en) | 1997-02-28 | 1998-09-03 | University Of Iowa Research Foundation | USE OF NUCLEIC ACIDS CONTAINING UNMETHYLATED CpG DINUCLEOTIDE IN THE TREATMENT OF LPS-ASSOCIATED DISORDERS |
DK1005368T3 (da) | 1997-03-10 | 2010-01-04 | Ottawa Hospital Res Inst | Anvendelse af nukleinsyrer, der indeholder ikke-metyleret CpG dinukleotid i kombination med alun som hjælpestoffer |
US6406705B1 (en) | 1997-03-10 | 2002-06-18 | University Of Iowa Research Foundation | Use of nucleic acids containing unmethylated CpG dinucleotide as an adjuvant |
EP1003531B1 (de) * | 1997-05-20 | 2007-08-22 | Ottawa Health Research Institute | Verfahren zur Herstellung von Nukleinsäurekonstrukten |
KR100578317B1 (ko) | 1997-05-20 | 2006-05-11 | 갈레니카 파마슈티칼스 인크. | 면역보강성 및 면역자극 활성을 갖는 트리테르펜 사포닌유사체 |
JP4101888B2 (ja) | 1997-06-06 | 2008-06-18 | ダイナバックス テクノロジーズ コーポレイション | 免疫刺激オリゴヌクレオチド、その組成物およびその使用方法 |
US6645495B1 (en) | 1997-08-29 | 2003-11-11 | Antigenics, Inc. | Compositions of saponin adjuvants and excipients |
US6013258A (en) * | 1997-10-09 | 2000-01-11 | Zycos Inc. | Immunogenic peptides from the HPV E7 protein |
AU760549B2 (en) * | 1998-04-03 | 2003-05-15 | University Of Iowa Research Foundation, The | Methods and products for stimulating the immune system using immunotherapeutic oligonucleotides and cytokines |
CA2328406A1 (en) | 1998-05-14 | 1999-11-18 | Hermann Wagner | Methods for regulating hematopoiesis using cpg-oligonucleotides |
DE69932717T2 (de) * | 1998-05-22 | 2007-08-09 | Ottawa Health Research Institute, Ottawa | Methoden und produkte zur induzierung mukosaler immunität |
US6562798B1 (en) | 1998-06-05 | 2003-05-13 | Dynavax Technologies Corp. | Immunostimulatory oligonucleotides with modified bases and methods of use thereof |
DE69929444T2 (de) * | 1998-08-10 | 2006-09-28 | Antigenics Inc., Woburn | Cpg-zusammensetzungen, saponin-adjuvantien und verfahren zu deren verwendung |
US20010034330A1 (en) | 1998-08-10 | 2001-10-25 | Charlotte Kensil | Innate immunity-stimulating compositions of CpG and saponin and methods thereof |
EP1117433A1 (de) | 1998-10-09 | 2001-07-25 | Dynavax Technologies Corporation | Anti hiv zusammensetzungen, die immunstimulierende polynukleotide und hiv antigene enthalten |
US6558670B1 (en) | 1999-04-19 | 2003-05-06 | Smithkline Beechman Biologicals S.A. | Vaccine adjuvants |
WO2000062800A2 (en) | 1999-04-19 | 2000-10-26 | Smithkline Beecham Biologicals Sa | Adjuvant composition comprising saponin and an immunostimulatory oligonucleotide |
ES2295229T3 (es) | 2000-10-18 | 2008-04-16 | Glaxosmithkline Biologicals S.A. | Vacunas contra canceres. |
US20030119774A1 (en) * | 2001-09-25 | 2003-06-26 | Marianna Foldvari | Compositions and methods for stimulating an immune response |
AR045702A1 (es) * | 2001-10-03 | 2005-11-09 | Chiron Corp | Composiciones de adyuvantes. |
AU2002347062B2 (en) * | 2001-10-06 | 2008-06-26 | Merial Ltd | CpG formulations and related methods |
SE0301998D0 (sv) * | 2003-07-07 | 2003-07-07 | Isconova Ab | Quil A fraction with low toxicity and use thereof |
GB0401239D0 (en) * | 2004-01-21 | 2004-02-25 | Molecularnature Ltd | Adjuvant compositions |
-
1999
- 1999-08-06 DE DE69929444T patent/DE69929444T2/de not_active Expired - Lifetime
- 1999-08-06 WO PCT/US1999/017956 patent/WO2000009159A1/en active IP Right Grant
- 1999-08-06 JP JP2000564661A patent/JP4620251B2/ja not_active Expired - Lifetime
- 1999-08-06 CA CA2340174A patent/CA2340174C/en not_active Expired - Lifetime
- 1999-08-06 ES ES99939711T patent/ES2257068T3/es not_active Expired - Lifetime
- 1999-08-06 EP EP99939711A patent/EP1104306B1/de not_active Expired - Lifetime
- 1999-08-06 US US09/369,941 patent/US7049302B1/en not_active Expired - Lifetime
- 1999-08-06 AU AU53953/99A patent/AU773204C/en not_active Expired
- 1999-08-06 DK DK99939711T patent/DK1104306T3/da active
- 1999-08-06 AT AT99939711T patent/ATE315405T1/de active
- 1999-08-06 PT PT99939711T patent/PT1104306E/pt unknown
-
2006
- 2006-03-10 US US11/373,806 patent/US7858589B2/en not_active Expired - Fee Related
Also Published As
Publication number | Publication date |
---|---|
US7858589B2 (en) | 2010-12-28 |
ATE315405T1 (de) | 2006-02-15 |
JP2002522510A (ja) | 2002-07-23 |
WO2000009159A1 (en) | 2000-02-24 |
CA2340174A1 (en) | 2000-02-24 |
AU5395399A (en) | 2000-03-06 |
ES2257068T3 (es) | 2006-07-16 |
US7049302B1 (en) | 2006-05-23 |
PT1104306E (pt) | 2006-05-31 |
AU773204C (en) | 2005-05-19 |
CA2340174C (en) | 2011-01-04 |
JP4620251B2 (ja) | 2011-01-26 |
US20060177458A1 (en) | 2006-08-10 |
WO2000009159A9 (en) | 2000-07-27 |
EP1104306A1 (de) | 2001-06-06 |
AU773204B2 (en) | 2004-05-20 |
DK1104306T3 (da) | 2006-05-22 |
EP1104306B1 (de) | 2006-01-11 |
DE69929444T2 (de) | 2006-09-28 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
DE69929444D1 (de) | Cpg-zusammensetzungen, saponin-adjuvantien und verfahren zu deren verwendung | |
ATE475668T1 (de) | Immunisierung durch impfung von dns transkriptionseinheit | |
IS4518A (is) | Nýtt lyfjaform fyrir bóluefni | |
MY125202A (en) | Vaccine | |
EP1594536A4 (de) | Adjuvante influenza-vakzine | |
HUP0103085A1 (hu) | Készítmények és eljárások poliszacharid elleni immunválasz kiváltására | |
NO20015073L (no) | Vaksiner | |
NZ331651A (en) | BSW17 peptide immunogens for vaccination against and treatment of allergy | |
EP1220925B8 (de) | Chlamydia antigene und entsprechende dna-fragmente und ihre verwendungen | |
ES2177927T3 (es) | Composicion para provocar una reaccion inmunologica a un determinante antigenico no proteinico. | |
BR0111834A (pt) | Composições adjuvante e imunogênica, e, método para eliciar uma resposta imune a um antìgeno | |
WO2003051288A3 (en) | Mycobacterial vaccine | |
AU2003242535A1 (en) | Improved polysaccharide and glycoconjugate vaccines | |
WO2000050073A3 (en) | Caulobacter lps immunoadjuvant | |
SE9903534D0 (sv) | Vaccin | |
WO2001015727A3 (en) | Compositions of immunostimulatory polymers and saponin adjuvants and uses thereof | |
DE69922212D1 (de) | Impfstoff enthaltend zytokin-induzierte heat shock proteine (hsp) | |
CY1107845T1 (el) | Γενετικα εμβολια με ανοσοενισχυτικο | |
DE69637435D1 (de) | Saponin-zusammensetzungen und deren verwendung | |
CA2133108A1 (en) | Pasteurella haemolytica type a-1 bacterin-toxoid vaccine | |
WO2004033483A3 (en) | Liposomal system and method of using same | |
ATE353226T1 (de) | Adjuvanszusammensetzung enthaltend fha oder ein fha-fragment in freier form | |
MY127452A (en) | Vaccines. | |
WO2003094829A3 (en) | Pathogen vaccines and methods for using the same | |
BR0013574A (pt) | Antìgeno vacina de moraxella |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
8364 | No opposition during term of opposition | ||
8328 | Change in the person/name/address of the agent |
Representative=s name: DERZEIT KEIN VERTRETER BESTELLT |